Trimix (Pge1;phent;pap)
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.
14,535 recalls, newest first.
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
CGMP Deviations: Failure of the manufacturer, Wockhardt Ltd, to adequately investigate customer complaints.
Failed Dissolution Specifications: OOS result during stability testing
Microbial Contamination of Non-Sterile Products: Product failed USP Microbial Limits Test.
Microbial Contamination of Non-Sterile Products: Product failed USP Microbial Limits Test.
Subpotent Drug
cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm did not adequately investigate customer complaints.
cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm did not adequately investigate customer complaints.
Labeling: Label Mix-Up: Product is incorrectly labeled as phenylephrine 50 mg in 0.9% sodium chloride rather than phenylephrine 50 mg in 5% dextrose.
Labeling: Label Error on Declared Strength: Labeled 3.1% Amino Acids but contains 3.3% Amino Acids
Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity
Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.
Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.
Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.
Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.